Mesoblast
MESO
#4332
Rank
C$3.34 B
Marketcap
C$25.97
Share price
3.59%
Change (1 day)
69.33%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : C$0.22 Billion

According to Mesoblast 's latest financial reports the company has C$0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30C$85.54 M-8.87%
2023-06-30C$93.86 M21.45%
2022-06-30C$77.28 M-54.29%
2021-06-30C$0.16 B-3.38%
2020-06-30C$0.17 B167.33%
2019-06-30C$65.45 M33.74%
2018-06-30C$48.94 M387.91%
2017-06-30C$10.03 M-64.59%
2016-06-30C$28.32 M7.46%
2015-06-30C$26.35 M545.45%
2014-06-30C$4.08 M-50.67%
2013-06-30C$8.27 M485.82%
2012-06-30C$1.41 M-99.44%
2011-06-30C$0.25 B647.71%
2010-06-30C$33.92 M78.69%
2009-06-30C$18.98 M32.26%
2008-06-30C$14.35 M12.35%
2007-06-30C$12.77 M46.52%
2006-06-30C$8.72 M-53.46%
2005-06-30C$18.73 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
C$3.07 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
C$0.18 M-99.92% Bahamas